MANILA — The Department of Science and Technology has reached Phase 2 clinical trials for a possible medicine against dengue, one of the world's leading mosquito-borne illnesses, the agency announced on Friday.
The phase 2 clinical trial, Montoya said, would investigate the medicine’s effectiveness, among others. “Kapag naging matagumpay ang mga susunod na trials ang proyektong ito po ay makakagawa po ng kauna-unahang gamot laban sa dengue,” he said. In December 2017, the government recalled Dengvaxia, after its manufacturer, France's Sanofi-Pasteur, said it could cause severe symptoms if given to those who have not had the mosquito-borne disease.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: